| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |